Resources
AVAC’s Resource Database contains educational and advocacy materials covering a wide range of issues on biomedical prevention of HIV, STIs, COVID-19 and emerging health threats—from research to rollout.
To search for clinical trials and detailed information on products in development, visit our Prevention Research & Development Database
Results
showing 1-10 of 124
PrEP That Booty: The latest on rectal microbicide research for the back door
Most of what we hear about regarding the HIV prevention pipeline is about long-acting, longer-acting, and even longer-acting products that deliver drug throughout the body and require a trained clinician to deliver.
Prevention Option:
Years Ahead in HIV Prevention Research: Time to Market
This new timeline shows the potential time points when the next-generation of HIV prevention options might find their way into new programs.
Prevention Option:
Current trends for investment in HIV prevention R&D by technology
Overall numbers by year. For more detailed information, visit www.hivresourcetracking.org.
Prevention Option:
The HIV Prevention Pipeline
This graphic shows currently available options for HIV prevention, newly approved and recommended treatment, and those in development.
Prevention Option:
The Years Ahead in Biomedical HIV Prevention Research
This graphic shows the updated status of large-scale prevention trials through 2024.
New Products Are Needed But a New Paradigm is Essential
This episode of PxPulse explores the shifting landscape in HIV prevention and how this moment gives the world a chance to finally reimagine how to DELIVER prevention.
Prevention Option:
The Future of ARV-Based Prevention and More
The pipeline of non-vaccine HIV prevention products includes oral pills, vaginal rings, vaginal and rectal gels, vaginal films, long-acting injectable antiretrovirals and more. Also pictured are the range of MPTs in development that aim to reduce...
Prevention Option:
Access to the Dapivirine Vaginal Ring: A timeline on progress
This infographic shows the timeline of progress for end user access to Dapivirine Vaginal Ring.
Prevention Option:
Statement on the Dapivirine Ring for Women: Call for Accelerated Global Access
A coalition of advocates applauds the WHO for its ongoing support and its 2021 recommendation of the dapivirine vaginal ring as an additional prevention option for women.
Prevention Option:
hivresourcetracking.org
The most up-to-date and comprehensive field-wide estimates for HIV prevention and R&D globally.
Prevention Option:
showing 1-10 of 124